Cargando…

L-citrulline supplementation reverses the impaired airway relaxation in neonatal rats exposed to hyperoxia

BACKGROUND: Hyperoxia is shown to impair airway relaxation via limiting L-arginine bioavailability to nitric oxide synthase (NOS) and reducing NO production as a consequence. L-arginine can also be synthesized by L-citrulline recycling. The role of L-citrulline supplementation was investigated in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sopi, Ramadan B, Zaidi, Syed IA, Mladenov, Mitko, Sahiti, Hazbije, Istrefi, Zahide, Gjorgoski, Icko, Lajçi, Azem, Jakupaj, Muharrem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487946/
https://www.ncbi.nlm.nih.gov/pubmed/22870905
http://dx.doi.org/10.1186/1465-9921-13-68
_version_ 1782248550563840000
author Sopi, Ramadan B
Zaidi, Syed IA
Mladenov, Mitko
Sahiti, Hazbije
Istrefi, Zahide
Gjorgoski, Icko
Lajçi, Azem
Jakupaj, Muharrem
author_facet Sopi, Ramadan B
Zaidi, Syed IA
Mladenov, Mitko
Sahiti, Hazbije
Istrefi, Zahide
Gjorgoski, Icko
Lajçi, Azem
Jakupaj, Muharrem
author_sort Sopi, Ramadan B
collection PubMed
description BACKGROUND: Hyperoxia is shown to impair airway relaxation via limiting L-arginine bioavailability to nitric oxide synthase (NOS) and reducing NO production as a consequence. L-arginine can also be synthesized by L-citrulline recycling. The role of L-citrulline supplementation was investigated in the reversing of hyperoxia-induced impaired relaxation of rat tracheal smooth muscle (TSM). METHODS: Electrical field stimulation (EFS, 2–20 V)-induced relaxation was measured under in vitro conditions in preconstricted tracheal preparations obtained from 12 day old rat pups exposed to room air or hyperoxia (>95% oxygen) for 7 days supplemented with L-citrulline or saline (in vitro or in vivo). The role of the L-citrulline/L-arginine cycle under basal conditions was studied by incubation of preparations in the presence of argininosuccinate synthase (ASS) inhibitor [α-methyl-D, L-aspartate, 1 mM] or argininosuccinate lyase inhibitor (ASL) succinate (1 mM) and/or NOS inhibitor [N(ω)-nitro-L-arginine methyl ester; 100 μM] with respect to the presence or absence of L-citrulline (2 mM). RESULTS: Hyperoxia impaired the EFS-induced relaxation of TSM as compared to room air control (p < 0.001; 0.5 ± 0.1% at 2 V to 50.6 ± 5.7% at 20 V in hyperoxic group: 0.7 ± 0.2 at 2 V to 80.0 ± 5.6% at 20 V in room air group). Inhibition of ASS or ASL, and L-citrulline supplementation did not affect relaxation responses under basal conditions. However, inhibition of NOS significantly reduced relaxation responses (p < 0.001), which were restored to control level by L-citrulline. L-citrulline supplementation in vivo and in vitro also reversed the hyperoxia-impaired relaxation. The differences were significant (p <0.001; 0.8 ± 0.3% at 2 V to 47.1 ± 4.1% at 20 V without L-citrulline; 0.9 ± 0.3% at 2 V to 68.2 ± 4.8% at 20 V with L-citrulline). Inhibition of ASS or ASL prevented this effect of L-citrulline. CONCLUSION: The results indicate the presence of an L-citrulline/L-arginine cycle in the airways of rat pups. L-citrulline recycling does not play a major role under basal conditions in airways, but it has an important role under conditions of substrate limitations to NOS as a source of L-arginine, and L-citrulline supplementation reverses the impaired relaxation of airways under hyperoxic conditions.
format Online
Article
Text
id pubmed-3487946
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34879462012-11-03 L-citrulline supplementation reverses the impaired airway relaxation in neonatal rats exposed to hyperoxia Sopi, Ramadan B Zaidi, Syed IA Mladenov, Mitko Sahiti, Hazbije Istrefi, Zahide Gjorgoski, Icko Lajçi, Azem Jakupaj, Muharrem Respir Res Research BACKGROUND: Hyperoxia is shown to impair airway relaxation via limiting L-arginine bioavailability to nitric oxide synthase (NOS) and reducing NO production as a consequence. L-arginine can also be synthesized by L-citrulline recycling. The role of L-citrulline supplementation was investigated in the reversing of hyperoxia-induced impaired relaxation of rat tracheal smooth muscle (TSM). METHODS: Electrical field stimulation (EFS, 2–20 V)-induced relaxation was measured under in vitro conditions in preconstricted tracheal preparations obtained from 12 day old rat pups exposed to room air or hyperoxia (>95% oxygen) for 7 days supplemented with L-citrulline or saline (in vitro or in vivo). The role of the L-citrulline/L-arginine cycle under basal conditions was studied by incubation of preparations in the presence of argininosuccinate synthase (ASS) inhibitor [α-methyl-D, L-aspartate, 1 mM] or argininosuccinate lyase inhibitor (ASL) succinate (1 mM) and/or NOS inhibitor [N(ω)-nitro-L-arginine methyl ester; 100 μM] with respect to the presence or absence of L-citrulline (2 mM). RESULTS: Hyperoxia impaired the EFS-induced relaxation of TSM as compared to room air control (p < 0.001; 0.5 ± 0.1% at 2 V to 50.6 ± 5.7% at 20 V in hyperoxic group: 0.7 ± 0.2 at 2 V to 80.0 ± 5.6% at 20 V in room air group). Inhibition of ASS or ASL, and L-citrulline supplementation did not affect relaxation responses under basal conditions. However, inhibition of NOS significantly reduced relaxation responses (p < 0.001), which were restored to control level by L-citrulline. L-citrulline supplementation in vivo and in vitro also reversed the hyperoxia-impaired relaxation. The differences were significant (p <0.001; 0.8 ± 0.3% at 2 V to 47.1 ± 4.1% at 20 V without L-citrulline; 0.9 ± 0.3% at 2 V to 68.2 ± 4.8% at 20 V with L-citrulline). Inhibition of ASS or ASL prevented this effect of L-citrulline. CONCLUSION: The results indicate the presence of an L-citrulline/L-arginine cycle in the airways of rat pups. L-citrulline recycling does not play a major role under basal conditions in airways, but it has an important role under conditions of substrate limitations to NOS as a source of L-arginine, and L-citrulline supplementation reverses the impaired relaxation of airways under hyperoxic conditions. BioMed Central 2012 2012-08-07 /pmc/articles/PMC3487946/ /pubmed/22870905 http://dx.doi.org/10.1186/1465-9921-13-68 Text en Copyright ©2012 Sopi et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Sopi, Ramadan B
Zaidi, Syed IA
Mladenov, Mitko
Sahiti, Hazbije
Istrefi, Zahide
Gjorgoski, Icko
Lajçi, Azem
Jakupaj, Muharrem
L-citrulline supplementation reverses the impaired airway relaxation in neonatal rats exposed to hyperoxia
title L-citrulline supplementation reverses the impaired airway relaxation in neonatal rats exposed to hyperoxia
title_full L-citrulline supplementation reverses the impaired airway relaxation in neonatal rats exposed to hyperoxia
title_fullStr L-citrulline supplementation reverses the impaired airway relaxation in neonatal rats exposed to hyperoxia
title_full_unstemmed L-citrulline supplementation reverses the impaired airway relaxation in neonatal rats exposed to hyperoxia
title_short L-citrulline supplementation reverses the impaired airway relaxation in neonatal rats exposed to hyperoxia
title_sort l-citrulline supplementation reverses the impaired airway relaxation in neonatal rats exposed to hyperoxia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487946/
https://www.ncbi.nlm.nih.gov/pubmed/22870905
http://dx.doi.org/10.1186/1465-9921-13-68
work_keys_str_mv AT sopiramadanb lcitrullinesupplementationreversestheimpairedairwayrelaxationinneonatalratsexposedtohyperoxia
AT zaidisyedia lcitrullinesupplementationreversestheimpairedairwayrelaxationinneonatalratsexposedtohyperoxia
AT mladenovmitko lcitrullinesupplementationreversestheimpairedairwayrelaxationinneonatalratsexposedtohyperoxia
AT sahitihazbije lcitrullinesupplementationreversestheimpairedairwayrelaxationinneonatalratsexposedtohyperoxia
AT istrefizahide lcitrullinesupplementationreversestheimpairedairwayrelaxationinneonatalratsexposedtohyperoxia
AT gjorgoskiicko lcitrullinesupplementationreversestheimpairedairwayrelaxationinneonatalratsexposedtohyperoxia
AT lajciazem lcitrullinesupplementationreversestheimpairedairwayrelaxationinneonatalratsexposedtohyperoxia
AT jakupajmuharrem lcitrullinesupplementationreversestheimpairedairwayrelaxationinneonatalratsexposedtohyperoxia